Cramer's top biotech with enormous value creation
January 15, 2015 at 18:42 PM EST
This biotech just upped its guidance for 2015. Jim Cramer thinks it could have a lot more in the pipeline for profits.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|